Alireza MEHMET ALI AYDINLAR Keshtkar

Dr. Alireza MEHMET ALI AYDINLAR Keshtkar

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2024 in Shiraz E-Medical Journal
Verified
Journal Article
Open access
PDF file
PYParsa Yazdanpanahi
Parsa Yazdanpanahi
FAFarnaz Atighi
Farnaz Atighi
AKAlireza MEHMET ALI AYDINLAR Keshtkar
Alireza MEHMET ALI AYDINLAR Keshtkar
RHReza Hamidi
Reza Hamidi
MRMohamadali Rezaeimanesh
Mohamadali Rezaeimanesh
MDMohammad Hossein Dabbaghmanesh
Mohammad Hossein Dabbaghmanesh
Background: Artificial intelligence (AI) can play a significant role in the future of thyroidology. Thyroid nodules are common conditions that may benefit from AI through more accurate and efficient diagnosis, risk stratification, and medical or surgical management. Objective: This paper aims to review the latest developments in AI applications for diagnosing and managing thyroid nodules and cancers. Methods: English full-text articles published in the PubMed and Google Scholar databases from January 2014 to March 2024 were collected and reviewed to provide a comprehensive understanding of the topic. A total of 45 studies were selected based on relevance, robust methodology, statistical significance, and broader topic coverage. Results: Artificial intelligence has emerged as a powerful tool for managing thyroid nodules. First, several studies have demonstrated how AI-powered ultrasound interpretation enhances the diagnosis and classification of nodules while reducing the need for invasive fine-needle aspiration (FNA) biopsies. Second, AI significantly improves the cytopathological differentiation between benign and malignant thyroid nodules by minimizing reliance on pathologists' expertise and implementing standardized diagnostic criteria. When cytopathology is inconclusive, AI also aids in identifying molecular markers from omics data, distinguishing between normal and cancerous cells. Moreover, AI tools have been developed for prognosis assessment, predicting distant metastasis, recurrence, and surveillance by integrating medical imaging features with molecular and clinical factors. Additionally, some AI tools are designed for intraoperative evaluation, improving surgical techniques and reducing complications during thyroidectomy. In non-surgical treatments, several models have been developed to optimize therapeutic doses of radioactive iodine (RAI) and predict the outcomes of new drug formulations. Conclusions: Artificial intelligence has the potential to assist physicians in accurate thyroid nodule diagnosis, classification, decision-making, optimizing treatment strategies, and improving patient outcomes. However, there are still limitations to this technology. Artificial intelligence-driven tools require further advancements before they can be fully integrated into clinical practice and replace specialists.

28 October 2025 in Health Science Reports
Verified
Journal Article
Open access
ANArzhang Naseri
Arzhang Naseri
FAFarnaz Atighi
Farnaz Atighi
AKAlireza MEHMET ALI AYDINLAR Keshtkar
Alireza MEHMET ALI AYDINLAR Keshtkar
PTPedram Talezadeh
Pedram Talezadeh
MBMarzieh Bakhshayeshkaram
Marzieh Bakhshayeshkaram
MDMohammad Hossein Dabbaghmanesh
Mohammad Hossein Dabbaghmanesh
Background and Aims: Understanding bone mass accumulation patterns and factors influencing them during growth is important for preventing osteoporosis later in life. This study investigated longitudinal changes in bone mineral content (BMC), bone mineral density (BMD), and bone mineral apparent density (BMAD) during growth, with the aim of estimating the age at which peak bone mass (PBM) is achieved in males and females. It also examined the effects of puberty, age, body mass index (BMI), sex, socioeconomic status (SES), and habitual exercise on these bone parameters during adolescence and early adulthood. Methods: This retrospective cohort study included 159 participants. Bone densitometry was performed using dual‐energy x‐ray absorptiometry (DXA) during two assessments. Anthropometric measurements were obtained, and demographic data, pubertal stage, medical history, SES, and exercise habits were collected through a structured questionnaire administered by a physician. Results: Rates of change in total body BMC (TBBMC) and BMD (TBBMD) decreased with advancing age and pubertal stage, with the highest rates observed at ages 9–11 and Tanner stage 1. Across all ages up to 18 years, males showed significantly higher rates than females. Peak TBBMC and TBBMD occurred at 25.7 and 26.2 years in males, and 24.8 and 24.0 years in females. After adjusting for bone size, BMAD peaks at the femoral neck and lumbar spine were 21.2 and 23.8 years in males, and 24.8 and 24.1 years in females. Linear mixed model analysis indicated that older age, higher BMI, male sex, higher SES (significant for BMD), and greater physical activity positively influenced TBBMC and TBBMD until peak values were reached. Conclusion: Bone accumulation was greater in adolescence than in early adulthood. PBM was generally reached in the mid‐third decade, with females attaining it earlier. Age, sex, BMI, SES, and exercise positively influenced TBBMC and TBBMD during adolescence and early adulthood.

7 December 2024 in Shiraz E-Medical Journal
Verified
Journal Article
Open access
PDF file
FAFarnaz Atighi
Farnaz Atighi
PYParsa Yazdanpanahi
Parsa Yazdanpanahi
AKAlireza MEHMET ALI AYDINLAR Keshtkar
Alireza MEHMET ALI AYDINLAR Keshtkar
AKAlireza Karimi
Alireza Karimi
ANArzhang Naseri
Arzhang Naseri
MDMohammad Hossein Dabbaghmanesh
Mohammad Hossein Dabbaghmanesh
Background: Dysregulation of thyroid function, manifesting as hyperthyroidism or hypothyroidism, can profoundly impact an individual's overall health. In this context, artificial intelligence (AI) applications have the potential to revolutionize diagnostic approaches, treatment strategies, and patient monitoring. Objectives: This study comprehensively reviews the latest literature on AI applications in thyroid functional and autoimmune disorders. Methods: An online search was conducted on databases using search queries crafted with MeSH terms related to AI and thyroid disorders. After screening, studies aligned with our research focus were selected for this narrative review. Results: Multiple studies have explored the use of AI technologies, including machine learning (ML) and deep learning (DL), to enhance laboratory workflows for thyroid function tests (TFT) and improve the accuracy of TFT interpretation by incorporating clinical data. In imaging, DL-based models have demonstrated the potential to assist less experienced radiologists in interpreting scintigraphy and ultrasound images. Artificial intelligence has also provided valuable insights into identifying diagnostic genes for thyroid-related autoimmune disorders and understanding the effects of environmental factors, such as chemicals, on thyroid gland function. Some ML models have been developed to predict the risk of hypothyroidism following radioiodine therapy (RAI). Furthermore, AI has shown promise in personalized levothyroxine dose adjustments, predicting treatment responses, and accurately diagnosing complications such as thyroid-associated ophthalmopathy (TAO). Finally, ML-based models forecasting the risk of suicide attempts in patients with major depressive disorder (MDD) and predicting pregnancy outcomes, such as gestational diabetes mellitus (GDM) and preterm delivery, based on TFT results, appear beneficial in addressing these significant health issues. Conclusions: The current state of AI in diagnosing and treating thyroid function disorders is promising, with applications primarily focused on improving diagnostic accuracy, consistency, and personalized treatment approaches. However, challenges remain that prevent these models from fully substituting professionals. Addressing these challenges is crucial to ensure AI effectively contributes to the management of patients with thyroid diseases.

28 October 2025 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
MSMaryam Salimi
Maryam Salimi
AKAlireza MEHMET ALI AYDINLAR Keshtkar
Alireza MEHMET ALI AYDINLAR Keshtkar
MAMohammad Kamal Abdelnaser
Mohammad Kamal Abdelnaser
SMSeyed Arad Mosalamiaghili
Seyed Arad Mosalamiaghili
NSNatsumi Saka
Natsumi Saka
JPJavad Parvizi
Javad Parvizi

5 February 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ANArzhang Naseri
Arzhang Naseri
ESEhsan Shojaeefard
Ehsan Shojaeefard
AKAlireza MEHMET ALI AYDINLAR Keshtkar
Alireza MEHMET ALI AYDINLAR Keshtkar
FAFarnaz Atighi
Farnaz Atighi
ASAmirreza Sabahizadeh
Amirreza Sabahizadeh
MDMohammad Hossein Dabbaghmanesh
Mohammad Hossein Dabbaghmanesh
Osteoporosis is a common comorbidity in end-stage liver disease (ESLD), yet its impact on waitlist survival remains underexplored, particularly in non-Western populations. This prospective cross-sectional study evaluated bone mineral density (BMD) and its association with mortality in 702 adult candidates, including 424 (60.4%) males and 278 (39.6%) females with an overall mean age of 45.13 ± 13.67 years, awaiting their first deceased-donor liver transplantation at a major referral center in Iran. BMD was assessed via dual-energy X-ray absorptiometry (DXA) at the lumbar spine, femoral neck, and total hip. Osteoporosis was present in 43.4% of patients, osteopenia in 36.9%, and only 19.7% had normal BMD. The mean Model for End-Stage Liver Disease (MELD) score was 18.1 ± 6.53. Patients with autoimmune hepatitis (AIH) exhibited the highest prevalence of osteoporosis (53.61%) among all etiologies. Multivariate Cox regression analysis revealed that osteoporosis was independently associated with increased waitlist mortality (HR = 1.90, 95% CI: 1.17–3.07). Conversely, primary sclerosing cholangitis (PSC) was associated with reduced mortality risk (HR = 0.42, 95% CI: 0.19–0.93). These findings underscore the high prevalence of bone disease in ESLD patients, identify AIH as a high-risk etiology for osteoporosis, and establish osteoporosis as a significant predictor of waitlist survival, highlighting the potential value of BMD assessment in pre-transplant risk stratification.

25 April 2025 in Injury
Verified
Journal Article
Closed access
AHAmir Human Hoveidaei
Amir Human Hoveidaei
SMSeyedArad Mosalamiaghili
SeyedArad Mosalamiaghili
AKAlireza MEHMET ALI AYDINLAR Keshtkar
Alireza MEHMET ALI AYDINLAR Keshtkar
SSSukritJ. Suresh
SukritJ. Suresh
JAJakob Adolf
Jakob Adolf
JCJanet D Conway
Janet D Conway